Earnings calendar/CGEM
Cullinan Therapeutics, Inc. (CGEM)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.85
Street estimate
Revenue target
$2.0M
Street estimate
Trailing EPS (avg 4Q)
$-0.78
Beat rate last 4: 75%
Latest EPS YoY
+24.3%
vs 2025-08-07
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.81 / $-0.80
-1.3%
Revenue actual / est
— / $3.7M
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.85 | Pending | — | $2.0M | Pending | — |
| 8/6/2026 | $-0.80 | $-0.81 | -1.3% | $3.7M | Pending | — |
| 5/14/2026upcoming | $-0.83 | Pending | — | $3.7M | Pending | — |
| 5/7/2026 | $-0.84 | $-0.75 | +10.3% | $3.7M | Pending | — |
| 3/12/2026upcoming | $-0.80 | Pending | — | $5.0M | Pending | — |
| 3/10/2026 | $-0.80 | $-0.77 | +3.8% | $5.0M | Pending | — |
| 3/5/2026upcoming | $-0.80 | Pending | — | $5.0M | Pending | — |
| 2/26/2026upcoming | $-0.80 | Pending | — | $5.0M | Pending | — |
| 11/6/2025 | $-0.95 | $-0.77 | +18.9% | $5.6M | Pending | — |
| 8/7/2025 | $-0.83 | $-1.07 | -28.9% | — | Pending | — |
| 5/8/2025 | $-0.78 | $-0.74 | +5.1% | — | Pending | — |
| 2/27/2025 | $-0.75 | $-0.73 | +2.7% | — | Pending | — |
| 11/7/2024 | $-0.78 | $-0.69 | +11.5% | — | Pending | — |
| 8/8/2024 | $-0.73 | $-0.75 | -2.7% | — | Pending | — |
| 5/15/2024 | $-0.90 | $-0.86 | +4.4% | — | Pending | — |
| 3/14/2024 | $-0.96 | $-0.54 | +43.7% | — | Pending | — |
| 11/8/2023 | $-0.91 | $-0.91 | 0.0% | — | Pending | — |
| 8/10/2023 | $-0.99 | $-0.82 | +17.2% | — | Pending | — |
| 5/11/2023 | $-0.84 | $-1.42 | -69.0% | — | Pending | — |
| 3/9/2023 | $-0.65 | $-0.59 | +9.2% | — | Pending | — |
| 11/14/2022 | $-0.97 | $-0.54 | +44.3% | — | Pending | — |
| 8/10/2022 | $5.47 | $-2.20 | -140.2% | $275.0M | Pending | — |
| 5/16/2022 | $-0.61 | $-0.27 | +55.7% | — | Pending | — |
| 3/17/2022 | $-0.47 | $-0.74 | -57.4% | — | $37.8M | — |
| 11/9/2021 | $-0.42 | $-0.40 | +4.8% | — | Pending | — |
| 8/10/2021 | $-0.42 | $-0.36 | +14.3% | — | Pending | — |
| 5/14/2021 | $0.07 | $-0.00 | -102.4% | $34.5M | $18.9M | -45.1% |
| 3/30/2021 | $-0.38 | $-2.86 | -652.6% | — | Pending | — |
| 1/6/2021 | — | $-0.26 | — | — | Pending | — |
| 6/30/2020 | — | $-0.45 | — | — | Pending | — |
| 3/31/2020 | — | $-0.26 | — | — | Pending | — |
| 12/31/2019 | — | $-0.24 | — | — | Pending | — |
| 9/30/2019 | — | $-6.82 | — | — | Pending | — |
| 6/30/2019 | — | $-5.94 | — | — | Pending | — |
| 3/31/2019 | — | $-5.94 | — | — | Pending | — |